Benign nodules can be big and cancers can be hopefully small, then the size treshold has not a robust basis in my opinion.
Likewise all the TIRADS systems are only B Mode based.
Advanced US technology can give highly detailed info on microvascular and stiffness features of the nodules. I believe that multiparametric US should be considered in all its performances.